Precision Oncology Comes of Age : Tumor-Agnostic Approaches

© 2020 Harborside™..

Colleen Lewis, MSN, ANP-BC, AOCNP®, and R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, presented on the new world of tumor-agnostic treatment approaches, including those aimed at managing patients with tumors that have high microsatellite instability (MSI-H) or neurotrophic receptor tyrosine kinase (NTRK) fusions. Learn about the clinical trial designs that enable development of these novel therapies, and discover how testing methodologies support precision medicine advances.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Journal of the advanced practitioner in oncology - 11(2020), 3 vom: 01. Apr., Seite 221-225

Sprache:

Englisch

Beteiligte Personen:

Lewis, Colleen [VerfasserIn]
Harvey, R Donald [VerfasserIn]

Links:

Volltext

Themen:

Journal Article

Anmerkungen:

Date Revised 19.02.2021

published: Print-Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.6004/jadpro.2020.11.3.2

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM321571592